45 papers found
Refreshing results…
The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications
A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection
Peri-operative Third Party Red Blood Cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
Pre-transplant Donor Specific Anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
178 20-Hete Contributes to the Blood Pressure Reduction Following Omega-3 Fatty Acid Supplementation in Patients With Chronic Kidney Disease:
Contributors
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
Myeloma and the Kidney
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial
The effects of ω3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: A randomized controlled trial
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials
38-Or
Diagnostic challenges associated with a complex case of cystic phaeochromocytoma presenting with malignant hypertension, microangiopathic haemolysis and acute renal failure [3]
Prevention of tunnelled HD catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study
Statin therapy improves brachial artery endothelial function in nephrotic syndrome
Homocysteine and nephrotic syndrome
Missing publications? Read more about our data sources.